{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:39:23Z","timestamp":1761759563661,"version":"build-2065373602"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Cow purulent catarrhal endometritis (PCE) is a common reproductive disorder in dairy cattle caused by bacterial infections. PCE impacts fertility, milk production, and animal health. Therapeutic approaches include systemic or intrauterine antibiotics. Unfortunately, the overuse of antibiotics in treating PCE drives the emergence of antibiotic-resistant bacteria, making infections difficult to treat and increasing food safety concerns due to antibiotic residues remaining in milk and meat products, posing health risks to consumers. Antimicrobial nanomaterials, particularly silver nanoparticles (AgNPs), provide an efficient alternative to combat multi-resistant bacteria, and the synergistic activity of AgNPs and antibiotics has been well documented, making the treatments of bacterial infections more efficient. Here, a comparative study is shown applying Argovit-C (AgNPs) and Enrocide as therapeutics for treating PCE in cattle. Intrauterine application of Argovit-C reduces the recovery time of cattle in comparison with Enrocide treatment as well as increases the sensitivity to antibiotics of\n                    <jats:italic>\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                    <\/jats:italic>\n                    isolates from cervical canal secretion samples of diseased cattle. The increased sensitivity was found to 24 antibiotics, including aminoglycosides, fluoroquinolones, tetracyclines, penicillins, cephalosporins, macrolides, polymyxin, rifampicin, and chloramphenicol. The increased sensitivity was much higher for those bacteria that did not show an active efflux effect. Furthermore, Argovit-C reduced the acquisition of\n                    <jats:italic>\n                      <jats:italic>blaDHA<\/jats:italic>\n                    <\/jats:italic>\n                    and\n                    <jats:italic>\n                      <jats:italic>blaGES<\/jats:italic>\n                    <\/jats:italic>\n                    resistance genes in\n                    <jats:italic>\n                      <jats:italic>E. coli<\/jats:italic>\n                    <\/jats:italic>\n                    , as well as the number of bacterial isolates without efflux effect. Overall, this translational study performed in 300 cows demonstrates the ability of Argovit-C AgNPs to combat bacterial infections, favoring an increase in bacterial susceptibility to antibiotics and reducing their ability to acquire antibiotic multi-resistant genes.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0335305","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:34:40Z","timestamp":1761759280000},"page":"e0335305","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["AgNPs treatment reduces time recovery and increases bacterial sensitivity to antibiotics in cow\u00b4s purulent catarrhal endometritis. A translational study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-6773","authenticated-orcid":true,"given":"Alejandro","family":"Huerta-Saquero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Nefedova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay N.","family":"Shkil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Pestryakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Bogdanchikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"1","key":"pone.0335305.ref001","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.theriogenology.2004.03.017","article-title":"Clinical evaluation of postpartum vaginal mucus reflects uterine bacterial infection and the immune response in cattle","volume":"63","author":"EJ Williams","year":"2005","journal-title":"Theriogenology"},{"issue":"9","key":"pone.0335305.ref002","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3168\/jds.S0022-0302(02)74302-6","article-title":"Defining and diagnosing postpartum clinical endometritis and its impact on reproductive performance in dairy cows","volume":"85","author":"SJ LeBlanc","year":"2002","journal-title":"J Dairy Sci"},{"issue":"8","key":"pone.0335305.ref003","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.theriogenology.2005.08.021","article-title":"Defining postpartum uterine disease in cattle","volume":"65","author":"IM Sheldon","year":"2006","journal-title":"Theriogenology"},{"issue":"6","key":"pone.0335305.ref004","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1095\/biolreprod.109.077370","article-title":"Defining postpartum uterine disease and the mechanisms of infection and immunity in the female reproductive tract in cattle","volume":"81","author":"IM Sheldon","year":"2009","journal-title":"Biol Reprod"},{"key":"pone.0335305.ref005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.21451\/1984-3143-AR1006","article-title":"Postpartum uterine infection and endometritis in dairy cattle","volume":"14","author":"IM Sheldon","year":"2017","journal-title":"Anim Reprod"},{"issue":"13","key":"pone.0335305.ref006","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/vr.155.13.383","article-title":"Minimum inhibitory concentrations of some antimicrobial drugs against bacteria causing uterine infections in cattle","volume":"155","author":"IM Sheldon","year":"2004","journal-title":"Vet Rec"},{"issue":"3","key":"pone.0335305.ref007","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkt443","article-title":"Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries","volume":"69","author":"I Chantziaras","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"pone.0335305.ref008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/fpd.2010.0730","article-title":"Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review","volume":"8","author":"SP Oliver","year":"2011","journal-title":"Foodborne Pathog Dis"},{"issue":"12","key":"pone.0335305.ref009","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3390\/antibiotics10121473","article-title":"Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics","volume":"10","author":"B Mubeen","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"pone.0335305.ref010","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.2147\/IJN.S104166","article-title":"Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii","volume":"11","author":"G Wan","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"pone.0335305.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224904","article-title":"Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane","volume":"14","author":"R Vazquez-Mu\u00f1oz","year":"2019","journal-title":"PLoS One"},{"key":"pone.0335305.ref012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2017.05.007","article-title":"Toxicity of silver nanoparticles in biological systems: does the complexity of biological systems matter?","volume":"276","author":"R Vazquez-Mu\u00f1oz","year":"2017","journal-title":"Toxicol Lett"},{"issue":"4","key":"pone.0335305.ref013","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pharmaceutics14040763","article-title":"AgNPs targeting the drug resistance problem of Staphylococcus aureus: susceptibility to antibiotics and efflux effect","volume":"14","author":"E Nefedova","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"pone.0335305.ref014","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.3390\/ijms23116024","article-title":"Silver nanoparticles targeting the drug resistance problem of Streptococcus dysgalactiae: susceptibility to antibiotics and efflux effect","volume":"23","author":"D Garibo Ruiz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0335305.ref015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/nano13061088","article-title":"Solution of the drug resistance problem of Escherichia coli with silver nanoparticles: efflux effect and susceptibility to 31 antibiotics","volume":"13","author":"E Nefedova","year":"2023","journal-title":"Nanomaterials (Basel)"},{"issue":"6","key":"pone.0335305.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217869","article-title":"Effect of antimicrobial nanocomposites on Vibrio cholerae lifestyles: Pellicle biofilm, planktonic and surface-attached biofilm","volume":"14","author":"A Meza-Villezcas","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"pone.0335305.ref017","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s11671-017-2222-6","article-title":"Nanoparticles as efflux pump and biofilm inhibitor to rejuvenate bactericidal effect of conventional antibiotics","volume":"12","author":"D Gupta","year":"2017","journal-title":"Nanoscale Res Lett"},{"key":"pone.0335305.ref018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fmicb.2018.00823","article-title":"Antibacterial efficacy of polysaccharide capped silver nanoparticles is not compromised by AcrAB-TolC efflux pump","volume":"9","author":"M Mishra","year":"2018","journal-title":"Front Microbiol"},{"issue":"28","key":"pone.0335305.ref019","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1021\/bi100268k","article-title":"Study of the multidrug membrane transporter of single living Pseudomonas aeruginosa cells using size-dependent plasmonic nanoparticle optical probes","volume":"49","author":"PD Nallathamby","year":"2010","journal-title":"Biochemistry"},{"issue":"9","key":"pone.0335305.ref020","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2478\/s11756-019-00269-0","article-title":"Synergistic antimicrobial potential of ciprofloxacin with silver nanoparticles conjugated to thiosemicarbazide against ciprofloxacin resistant Pseudomonas aeruginosa by attenuation of MexA-B efflux pump genes","volume":"74","author":"M Abdolhosseini","year":"2019","journal-title":"Biologia"},{"issue":"6","key":"pone.0335305.ref021","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jobm.201900712","article-title":"Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates","volume":"60","author":"R Behdad","year":"2020","journal-title":"J Basic Microbiol"},{"issue":"4","key":"pone.0335305.ref022","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/molecules26041004","article-title":"Tannic acid-stabilized silver nanoparticles used in biomedical application as an effective antimelioidosis and prolonged efflux pump inhibitor against melioidosis causative pathogen","volume":"26","author":"O Srichaiyapol","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"pone.0335305.ref023","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1039\/C9RA09018E","article-title":"Argovit\u2122 silver nanoparticles to fight Huanglongbing disease in Mexican limes (Citrus aurantifolia Swingle)","volume":"10","author":"JL Stephano-Hornedo","year":"2020","journal-title":"RSC Adv"},{"key":"pone.0335305.ref024","article-title":"Evaluation of a new Argovit as an antiviral agent included in feed to protect the shrimp Litopenaeus vannamei against White Spot Syndrome Virus infection","volume":"8","author":"CR Romo-Qui\u00f1onez","year":"2020","journal-title":"PeerJ"},{"issue":"5","key":"pone.0335305.ref025","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.nano.2016.01.021","article-title":"Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo","volume":"12","author":"B Borrego","year":"2016","journal-title":"Nanomedicine"},{"key":"pone.0335305.ref026","doi-asserted-by":"crossref","unstructured":"Bogdanchikova N, Huerta-saquero A, Nanociencias C De, Aguzvet CV, Picos-d\u00edaz PL. Silver nanoparticles composition for treatment of distemper in dogs Roberto V\u00e1zquez-Mu\u00f1oz Antonio Pena-Jasso Gildardo Aguilar-Uzcanga Alexey Pestryakov Vasilii Burmistrov Oxana Martynyuk Roberto Luna-V\u00e1zquez-G\u00f3mez and Horacio Almanza. 2016;13: 227\u201337.","DOI":"10.1504\/IJNT.2016.074536"},{"issue":"4","key":"pone.0335305.ref027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/mi11040441","article-title":"Electrospun fibers and sorbents as a possible basis for effective composite wound dressings","volume":"11","author":"AS \u00c1lvarez-Su\u00e1rez","year":"2020","journal-title":"Micromachines (Basel)"},{"key":"pone.0335305.ref028","doi-asserted-by":"crossref","first-page":"1440065","DOI":"10.3389\/fmicb.2024.1440065","article-title":"Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics","volume":"15","author":"AS Rodrigues","year":"2024","journal-title":"Front Microbiol"},{"key":"pone.0335305.ref029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/IDR.S234425","article-title":"Synergistic and antagonistic effects of metal nanoparticles in combination with antibiotics against some reference strains of pathogenic microorganisms","volume":"13","author":"UH Abo-Shama","year":"2020","journal-title":"Infect Drug Resist"},{"key":"pone.0335305.ref030","first-page":"522064","article-title":"Silver nanoparticles at biocompatible dosage synergistically increases bacterial susceptibility to antibiotics","volume":"11","author":"DS Ipe","year":"2020","journal-title":"Frontiers in Microbiology"},{"issue":"3","key":"pone.0335305.ref031","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1021\/acsanm.1c03891","article-title":"Synergistic effects between metal nanoparticles and commercial antimicrobial agents: a review","volume":"5","author":"AI Ribeiro","year":"2022","journal-title":"ACS Appl Nano Mater"},{"issue":"3","key":"pone.0335305.ref032","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dkm226","article-title":"Class A carbapenemases","volume":"60","author":"J Walther-Rasmussen","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"pone.0335305.ref033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1381612811306020209","article-title":"Mechanisms of \u03b2 -lactam resistance among Pseudomonas aeruginosa","volume":"19","author":"D J. Wolter","year":"2012","journal-title":"CPD"},{"issue":"9","key":"pone.0335305.ref034","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.9734\/BBJ\/2014\/10570","article-title":"AmpC-BETA lactamases among enterobacteriaceae isolated at a Tertiary Hospital, South Western Uganda","volume":"4","author":"M Nakaye","year":"2014","journal-title":"Br Biotechnol J"},{"key":"pone.0335305.ref035","unstructured":"Berge\u2019s manual of determinative bacteriology: Ninth Edition | VWR. Available from: https:\/\/mx.vwr.com\/store\/product\/8867643\/null"},{"key":"pone.0335305.ref036","volume-title":"MIC distributions and epidemiological cut-off value (ECOFF) setting","author":"European Committee on Antimicrobial Susceptibility Testing.","year":"2017"},{"key":"pone.0335305.ref037","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jgar.2022.09.005","article-title":"Genomic landscape of blaGES-5- and blaGES-24-harboring Gram-negative bacteria from hospital wastewater: emergence of class 3 integron-associated blaGES-24 genes","volume":"31","author":"S Takizawa","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"pone.0335305.ref038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12941-017-0189-x","article-title":"Occurrence of bla DHA-1 mediated cephalosporin resistance in Escherichia coli and their transcriptional response against cephalosporin stress: a report from India","volume":"16","author":"B Ingti","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:34:49Z","timestamp":1761759289000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335305"}},"subtitle":[],"editor":[{"given":"Sherin Reda","family":"Rouby,","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335305","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}